Artificial Intelligence Technology′s Use and Efficacy in Cytopathology

Arturo Brunetti^*
*Correspondence: Arturo Brunetti, Department of Cell Physiology and Metabolism, University of Geneva, CH-1211 Geneva, Switzerland, Email:

Introduction

Cytopathology is a branch of pathology that focuses on the study of cells and their structures in order to diagnose diseases. It involves the examination of cells from various body tissues, fluids, and organs to determine whether they are normal or abnormal. Cytopathology is an important tool in the diagnosis of cancer, infectious diseases, autoimmune diseases, and other conditions. The field of cytopathology has undergone significant advancements in recent years, with the development of new technologies and techniques that enable the detection of abnormalities in cells at an early stage. These advancements have improved the accuracy and sensitivity of cytopathology tests, leading to more accurate diagnoses and better patient outcomes [1].

Description

The history of cytopathology can be traced back to the late 19th century, when scientists first began to study cells under the microscope. The first cytopathology test was performed by George Papanicolaou in 1928, who used vaginal smears to detect abnormal cells in women with cervical cancer. Papanicolaou's technique, known as the Papanicolaou smear or Pap test, revolutionized the field of cytopathology by providing a non-invasive and cost-effective method for detecting cervical cancer at an early stage. The Pap test is now widely used as a screening tool for cervical cancer, and has helped to reduce the incidence of this disease worldwide. In the decades that followed, cytopathology continued to evolve, with new techniques and technologies being developed to improve the accuracy and sensitivity of cell analysis. These include fine needle aspiration (FNA) biopsy, liquid-based cytology, and computer-assisted image analysis [2].

Cytopathology techniques can be broadly classified into two categories: exfoliative cytology and aspiration cytology. Exfoliative cytology involves the collection of cells that have been shed from the surface of an organ or tissue, such as the cells in a Pap smear. Aspiration cytology, on the other hand, involves the collection of cells using a needle, such as in a FNA biopsy. Aspiration cytology involves the use of a needle to collect cells from a specific area of the body. The most common type of aspiration cytology is fine needle aspiration (FNA) biopsy, which is used to diagnose cancer and other diseases. During a FNA biopsy, a small needle is inserted into the area of concern, and a sample of cells is collected. The sample is then smeared onto a glass slide and sent to a laboratory for analysis. FNA biopsy is commonly used to diagnose breast cancer, thyroid cancer, and lung cancer, among other types of cancer [3].

Cytopathology is the study of cells and their abnormalities, with a focus on the diagnosis of diseases through examination of cells under the microscope. This field is essential in diagnosing and treating various diseases, including cancer, and is often used in conjunction with other diagnostic tests such as imaging and blood tests. The field of cytopathology has a rich history dating back to the early 20^th century, with the development of the Pap smear by Dr. George Papanicolaou in the 1920s. This test revolutionized the field of gynecology by enabling early detection of cervical cancer through examination of cervical cells. Since then, the field of cytopathology has continued to evolve with the development of new techniques and technologies, enabling the diagnosis of a broader range of diseases.

One of the main applications of cytopathology is the diagnosis of cancer. The examination of cells under the microscope can identify abnormal cells, including those indicative of cancer. In some cases, the examination of cells can even identify the specific type of cancer. This information is crucial in developing a treatment plan tailored to the patient's specific condition. In addition to cancer diagnosis, cytopathology is used in the diagnosis of various non-cancerous conditions, including infections and inflammatory diseases. For example, the examination of cells from a patient with pneumonia can identify the type of bacteria causing the infection, enabling targeted treatment with antibiotics. One of the key advantages of cytopathology is its non-invasive nature. In many cases, cells can be obtained through minimally invasive procedures such as fine-needle aspiration or brushing. This reduces the risk of complications and enables more frequent monitoring of certain conditions. For example, patients with a history of thyroid cancer may undergo regular fine-needle aspiration to monitor for recurrence of the cancer.

The use of cytopathology is not limited to diagnosis alone. It can also play an important role in monitoring treatment response and disease progression. For example, in patients with lymphoma, examination of cells from a lymph node biopsy can provide information about the response to chemotherapy and whether the disease is progressing. The field of cytopathology has continued to evolve with the development of new techniques and technologies. One such technology is the liquid-based cytology (LBC) technique, which involves suspending cells in a liquid medium before examination under the microscope. This technique has several advantages over traditional smear preparations, including a higher diagnostic yield and reduced rates of false negatives [4,5].

Conclusion

The role of cytopathology is not limited to traditional laboratory settings. It is also used in a variety of clinical settings, including primary care clinics and outpatient centers. In these settings, rapid on-site evaluation (ROSE) is often used to enable real-time interpretation of cytology results. This can expedite diagnosis and treatment, particularly in cases where time is of the essence, such as in suspected cases of cancer. The field of cytopathology is constantly evolving, and new techniques and technologies are being developed to improve diagnosis and treatment. One area of research that is gaining increasing attention is the use of artificial intelligence (AI) in cytopathology. Another technology that has revolutionized the field of cytopathology is the use of molecular testing. This involves the examination of cells for specific genetic or molecular markers that are indicative of certain diseases or treatment responses. For example, in patients with lung cancer, molecular testing can identify specific mutations that are targetable with certain medications, enabling personalized treatment. AI has the potential to improve the accuracy and speed of diagnosis, particularly in cases where multiple samples need to be examined.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Liang, Yuqing, Yongping Liang, Hualei Zhang and Baolin Guo, et al. "Antibacterial biomaterials for skin wound dressing." Asian J Pharm Sci (2022).

Google Scholar, Crossref, Indexed at

2. Liang, Yongping, Jiahui He and Baolin Guo. "Functional hydrogels as wound dressing to enhance wound healing." ACS nano 15 (2021): 12687-12722.

Google Scholar, Crossref, Indexed at

3. Grossman, David C., Susan J. Curry, Douglas K. Owens and Kirsten Bibbins-Domingo, et al. "Screening for prostate cancer: US Preventive Services Task Force recommendation statement." Jama 319 (2018): 1901-1913.

Google Scholar, Crossref, Indexed at

4. Xue, Xu, Yan Hu, Sicheng Wang and Xiao Chen, et al. "Fabrication of physical and chemical crosslinked hydrogels for bone tissue engineering." Bioact Mater 12 (2022): 327-339.

Google Scholar, Crossref, Indexed at

5. Zhang, Luzhong, Xin Liu, Guicai Li and Peiyuan Wang, et al. "Tailoring degradation rates of silk fibroin scaffolds for tissue engineering." J Biomed Mater Res 107 (2019): 104-113.
 

Google Scholar, Crossref, Indexed at